Skip to main content
Log in

Frequency and causes of prevalence of p.Arg894* mutation in CLCN1 gene responsible for development of thomsen’s and becker’s myotonias in russian population

  • Human Genetics
  • Published:
Russian Journal of Genetics Aims and scope Submit manuscript

Abstract

Thomsen’s (TM) and Becker’s (BM) myotonias are nondystrophic myotonias. At present, 150 mutations in the CLCN1 gene, which results in the development of TM and BM, have been described. The c.2680C>T (p.Arg894*) is the most common mutation. In the Northern Scandinavian countries, the population frequency of this mutation is 0.87%, while in the Russian Federation, it is equal to 1.2% (this study). Based on the results of a molecular-genetic analysis of CLCN1 gene in patients with nondystrophic myotonias, the calculated frequency of TM and BM in Russia is 1: 8165 and 1: 710, respectively. We have conducted haplotype analysis using microsatellite markers and intragene SNP, which has shown that the prevalence of p.Arg894* mutation in Russia results from the founder effect, and the time of its scattering is 3680 ± 1240 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Meyer-Kleine, C., Steinmeyer, K., Riecker, K., et al., Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia, Am. J. Hum. Genet., 1995, vol. 57, no. 6, pp. 1325–1334.

    PubMed  CAS  Google Scholar 

  2. Papponen, H., Toppinen, T., Baumann, P., et al., Founder mutations and the high prevalence of myotonia congenita in northern Finland, J. Neurol., 1999, vol. 53, no. 2, pp. 297–302.

    Article  CAS  Google Scholar 

  3. Sun, C., Tranebjaerg, L., Torbergsen, T., et al., Spectrum of CLCN1 mutations in patients with myotonia congenita in northern Scandinavia, Eur. J. Hum. Genet., 2001, vol. 9, no. 12, pp. 903–909.

    Article  PubMed  CAS  Google Scholar 

  4. Trip, J., Drost, G., Verbove, D.J., et al., In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia, Eur. J. Hum. Genet., 2008, vol. 16, no. 8, pp. 921–929.

    Article  PubMed  CAS  Google Scholar 

  5. Mankodi, A., Myotonic disorders, Neurol. India, 2008, vol. 56, no. 3, pp. 298–304.

    Article  PubMed  Google Scholar 

  6. George, A.L., Crackower, M.A., Abdalla, J.A., et al., Molecular basis of Thomsen’s disease (autosomal dominant myotonia congenita), Nat. Genet., 1993, vol. 3, no. 4, pp. 305–310.

    Article  PubMed  CAS  Google Scholar 

  7. Koty, P.P., Pegoraro, E., Hobson, G., et al., Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect, Neurology, 1996, vol. 47, no. 4, pp. 963–968.

    Article  PubMed  CAS  Google Scholar 

  8. Koch, M.C., Steinmeyer, K., Lorenz, C., et al., The skeletal muscle chloride channel in dominant and recessive human myotonia, Science, 1992, vol. 257, no. 5071, pp. 797–800.

    Article  PubMed  CAS  Google Scholar 

  9. Ivanova, E.A., Dadali, E.L., Fedotov, V.P., et al., The spectrum of CLCN1 gene mutations in patients with nondystrophic Thomsen’s and Becker’s myotonias, Russ. J. Genet., 2012, vol. 49, no. 9, pp. 952–961.

    Article  Google Scholar 

  10. Bengtsson, B.O. and Thomson, G., Measuring the strength of associations between HLA antigens and diseases, Tissue Antigens, 1981, vol. 18, pp. 356–363.

    Article  PubMed  CAS  Google Scholar 

  11. Bliznets, E.A., Zinchenko, R.A., Tverskaya, S.M., et al., Population frequency and the age of mutation in c.807+5G>A, causing autosomal recessive osteopetrosis in Chuvashia, Med. Genet., 2006, vol. 5, no. 9, pp. 9–14.

    Google Scholar 

  12. Labuda, D., Zietkiewicz, E., and Labuda, M., The genetic clock and the age of the founder effect in growing populations: A lesson from French Canadians and Ashkenazim, Am. J. Hum. Genet., 1997, vol. 61, pp. 768–771.

    Article  PubMed  CAS  Google Scholar 

  13. Risch, N., de Leon, D., Ozelius, L., et al., Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population, Nat. Genet., 1995, vol. 9, no. 2, pp. 152–159.

    Article  PubMed  CAS  Google Scholar 

  14. Colombo, R., Age estimate of the N370S mutation causing Gaucher disease in Ashkenazi Jews and European populations: a reappraisal of haplotype data, Am. J. Hum. Genet., 2000, vol. 66, pp. 692–697.

    Article  PubMed  CAS  Google Scholar 

  15. Durst, R., Colombo, R., Shpitzen, S., et al., Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews, Am. J. Hum. Genet., 2001, vol. 68, pp. 1172–1188.

    Article  PubMed  CAS  Google Scholar 

  16. Zielonka, D., Jurkat-Rott, K., Stachowiak, P., et al., A Becker myotonia patient with compound heterozygosity for CLCN1 mutations and Prinzmetal angina pectoris, Neuromuscular Disord., vol. 22, no. 4, pp. 355–360.

  17. Dun, M., Colding-Jørgensen, E., and Grunnet, M., Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype, Eur. J. Hum. Genet., 2004, vol. 12, no. 9, pp. 738–743.

    Article  Google Scholar 

  18. Sangiuolo, F., Botta, A., Mesoraca, A., et al., Identification of five new mutations and three novel polymorphisms in the muscle chloride channel gene (CLCN1) in 20 Italian patients with dominant and recessive myotonia congenita, Hum. Mutat., 1998, vol. 11, no. 4, p. 331.

    Article  PubMed  CAS  Google Scholar 

  19. Dupré, N., Chrestian, N., Bouchard, J.P., et al., Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians, Neuromuscular Disord., 2009, vol. 19, no. 5, pp. 330–334.

    Article  Google Scholar 

  20. Mazón, M.J., Barros, F., de la Peña, P., et al., Screening for mutations in Spanish families with myotonia: functional analysis of novel mutations in CLCN1 gene, Neuromuscular Disord., 2012, vol. 22, no. 3, pp. 303–304.

    Google Scholar 

  21. Lin, M.J., You, T.H., Pan, H., et al., Functional characterization of CLCN1 mutations in Taiwanese patients with myotonia congenita via heterologous expression, Biochem. Biophys. Res. Commun., 2006, vol. 351, no. 4, pp. 1043–1047.

    Article  PubMed  CAS  Google Scholar 

  22. Guzeva, V.I., Rukovodstvo po detskoi nevrologii (Guide to Child Neurology), St. Petersburg: Med. Inform. Agenstvo, 2009.

    Google Scholar 

  23. Gudz’-Markov, A.V., Indoevropeiskaya istoriya Evrazii: Proiskhozhdenie slavyanskogo mira, (Indo-European History of Eurasia: Origin of Slavic World), Moscow: Rikel, 1995.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. A. Ivanova.

Additional information

Original Russian Text © E.A. Ivanova, A.V. Polyakov, 2013, published in Genetika, 2013, Vol. 49, No. 12, pp. 1407–1415.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ivanova, E.A., Polyakov, A.V. Frequency and causes of prevalence of p.Arg894* mutation in CLCN1 gene responsible for development of thomsen’s and becker’s myotonias in russian population. Russ J Genet 49, 1227–1235 (2013). https://doi.org/10.1134/S1022795413090044

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1022795413090044

Keywords

Navigation